Tag Archives: registration

RESI JPM 2018 Early Bird Registration Is Open

26 Oct

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

On January 9th, 2018, the Redefining Early Stage Investments (RESI) Conference will join the JPM fray again for our largest event yet in San Francisco.

In the last two RESI JPM conferences, we had to close registrations two weeks early as we’d reached capacity. In RESI JPM 2018, LSN is expecting to bring together 500+ fundraising CEOs and 500+ early stage investors from around the globe and host over 2000 scheduled and ad hoc meetings in one high energy day.

RESI JPM will offer early stage companies and investors an opportunity to get the most out of the wild week when the biotech and medtech world gathers by the Bay. Register early to secure your partnering meetings with investors and strategic partners that are a fit.

New at RESI Boston and RESI NYC: Academic and Tech Transfer Registration

14 Sep

By Lauren Schulkamp, Business Development Manager-RESI Conference Series, LSN

lauren-wp

We are excited to welcome academic scientists and tech transfer professionals to RESI for the first time.  The Redefining Early Stage Investments Conference (RESI) is now offering a special academic rate to universities, institutes, tech transfer offices, and hospitals to shine the spotlight on some of the most innovative emerging technology.  If you’d like to come to RESI to network with over 300 early stage life science investors, you can get an academic registration online now.  Academic registration includes the following:

  • All day access pass to 24 panels & workshops, RESI’s ad hoc meeting area, Exhibit Hall and Innovation Challenge, meals, and the evening Cocktail Reception
  • Full day of networking with early stage investors and pharma external innovation staff
  • Learn from life science investors and understand their investment strategies
  • Listen to current fundraising life science CEOs describe their process in developing a fundraising strategy
  • Get to know the experts as they explain the valuation process, organizing an outbound marketing campaign, negotiating term sheets, and other post-academia commercialization topics

Click here for a complete list of RESI Boston Panels & Workshops

** RESI Partnering is not included in the academic and tech transfer registration

To qualify you must:

  • Be affiliated with a non-profit certified 501(c)(3) organization. This includes universities, institutes, tech transfer offices, and hospitals
  • Register with an email address corresponding with the organization you are representing
  • Provide proof of current position – this can be done by sending proof via email to resi@lifesciencenation.com

RESI San Diego, June 19, 2017 Early Bird Registration is Now Open

13 Apr

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

The 13th Redefining Early Stage Investments (RESI) Conference will take place in San Diego on Monday June 19th, 2017 during the 2017 BIO week. RESI SD will offer early stage companies and investors an opportunity to get the most out of the busy week when the biotech and medtech world gathers in San Diego.

Why RESI?

  • 500+ early stage investors seeking innovations across therapeutics, medical device, diagnostics and healthcare IT
  • Meet with 10 categories of early stage global investors
  • Great ROI – 16 to 20 meetings in one day that are a fit for your stage of development & product
  • 24 investor panels and entrepreneur workshops covering a wide variety of topics
  • Kick off your BIO week at a unique investor-centric gathering for early stage companies

Venue: The Westin San Diego Gaslamp Quarter, 910 Broadway Circle, San Diego, CA 92101

About RESI

RESI is a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks including Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more. Through the RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.

RESI SF 2017 Will Definitely Sell Out! Register Early Bird

15 Sep

By Dennis Ford, Founder & CEO, LSN

dennis-websit

After the huge success of RESI Boston, which attracted over 700 attendees for an unprecedented number of face to face meetings, it’s time to look ahead to this winter’s conference season. RESI will be joining the JPM fray for our largest event yet. The 11th Redefining Early Stage Investments (RESI) Conference will take place on January 10th in San Francisco.

141580219028682490

001

2016 has seen a grand RESI tour, beginning with a sellout event in San Francisco, then to Houston, and up to Toronto for our first international RESI event, and home to Boston in the fall. For 2017 we’ll once again open the year with a splash in San Francisco. With other events focusing on late stage or publicly traded companies, RESI San Francisco will offer early stage companies and investors an opportunity to get the most out of the wild week when the biotech and medtech world gathers by the Bay. As RESI SF is highly likely to hit capacity again, we encourage you to register early.

RESI is a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks including Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more. Through the RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.

002

162801425610010374

%d bloggers like this: